Vancomycin IV Bags Recalled Due to Lack of Sterility Assurance
Central Admixture Pharmacy Services is recalling 2,914 bags of vancomycin IV medication nationwide due to lack of assurance of sterility caused by missing validation data for decontamination cycles.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of sterile injectable medication where validation data for sterilization is lacking. Though no illnesses or injuries have been reported, the potential for contamination in direct-injection products constitutes a risk-of-harm scenario.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 2,914 bags of vancomycin 1.5 g/250mL added to 5% dextrose IV bags that were distributed nationwide. The affected lot numbers are: 36-239516 and 36-239517 (expiring 7/12/2023), 36-239989 (expiring 7/13/2023), 36-240798 (expiring 7/17/2023), 36-241133 (expiring 7/19/2023), 36-241981 (expiring 7/24/2023), 36-242717 (expiring 7/26/2023), and 36-245577 (expiring 8/2/2023).
The recall is due to lack of assurance of sterility. Validation data for decontamination cycles is lacking, which means the manufacturer cannot confirm that these IV bags have been properly sterilized and are safe for use.
Healthcare providers and patients who have received any of these products should contact Central Admixture Pharmacy Services or their healthcare provider. Any remaining stock of these products should not be used.
The recalled product
- Product
- vancomycin 1.5 g/250mL added to 5% dextrose, 6 mg/mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6075-1
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — IV Admixture
- Affected units
- 2,914
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (15)
- Lot: 36-239516
- 36-239517
- Exp. 7/12/2023
- 36-239989
- Exp. 7/13/2023
- 36-240798
- Exp. 7/17/2023
- 36-241133
- Exp. 7/19/2023
- 36-241981
- Exp. 7/24/2023
- 36-242717
- Exp. 7/26/2023
- 36-245577
- Exp. 8/2/2023.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 95 recalled by Central Admixture Pharmacy Services, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 95 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services, Inc.
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighInjectable Lidocaine Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22